Genetic polymorphisms in carcinogen metabolism and their association to hereditary nonpolyposis colon cancer

被引:40
作者
Moisio, AL
Sistonen, P
Mecklin, JP
Järvinen, H
Peltomäki, P
机构
[1] Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland
[2] Finnish Red Cross, Ctr Blood Transfus, Helsinki, Finland
[3] Cent Hosp Jyvaskyla, Dept Surg, Jyvaskyla, Finland
[4] Univ Helsinki, Cent Hosp, Dept Surg 2, Helsinki, Finland
[5] Ohio State Univ, Ctr Comprehens Canc, Div Human Canc Genet, Columbus, OH 43210 USA
关键词
D O I
10.1016/S0016-5085(98)70017-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The phenotype of hereditary nonpolyposis colorectal cancer shows interfamilial and intrafamilial variation even in the presence of identical predisposing mutations, suggesting the existence of additional phenotype determinants. The modifying role of genetic polymorphisms in loci involved in carcinogen metabolism was studied. Methods: We focused on colon cancers from kindreds sharing one of two predisposing mutations (mutation 1 or 2) in the mismatch repair gene MLH1 (78 and 14 tumors, respectively). Polymorphisms in N-acetyltransferase 1 (NAT1) and glutathione S-transferase (GST) M1 and GSTT1 were investigated, Results: The NAT1 allele 10 was associated with lower median age at diagnosis in both groups. In mutation 1 group, the NAT1 allele 10 was a risk factor for distal tumor location, both alone (P = 0.028) and combined with the GSTT1-positive genotype (P = 0.008). On the other Rand, the combined null genotype of GSTM1 and GSTT1 was associated with proximal tumors, Associations with tumor location were not observed in patients with mutation 2, probably reflecting a small sample size. Conclusions: The results suggest that genetic polymorphisms in carcinogen metabolism modify the age of onset and tumor location in individuals with inherited deficiency of DNA mismatch repair.
引用
收藏
页码:1387 / 1394
页数:8
相关论文
共 40 条
[1]   Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome [J].
Aarnio, M ;
Mecklin, JP ;
Aaltonen, LA ;
NystromLahti, M ;
Jarvinen, HJ .
INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (06) :430-433
[2]  
Akiyama Y, 1997, CANCER RES, V57, P3920
[3]  
BELL DA, 1995, CANCER RES, V55, P3537
[4]  
BELL DA, 1995, CANCER RES, V55, P5226
[5]   COLORECTAL-CANCER - EVIDENCE FOR DISTINCT GENETIC CATEGORIES BASED ON PROXIMAL OR DISTAL TUMOR LOCATION [J].
BUFILL, JA .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (10) :779-788
[6]   GLUTATHIONE-S-TRANSFERASE M1 AND T1 POLYMORPHISMS - SUSCEPTIBILITY TO COLON-CANCER AND AGE-OF-ONSET [J].
CHENEVIXTRENCH, G ;
YOUNG, J ;
COGGAN, M ;
BOARD, P .
CARCINOGENESIS, 1995, 16 (07) :1655-1657
[7]   DNA MISMATCH REPAIR AND CANCER [J].
CHUNG, DC ;
RUSTGI, AK .
GASTROENTEROLOGY, 1995, 109 (05) :1685-1699
[8]   Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis [J].
Cormier, RT ;
Hong, KH ;
Halberg, RB ;
Hawkins, TL ;
Richardson, P ;
Mulherkar, R ;
Dove, WF ;
Lander, ES .
NATURE GENETICS, 1997, 17 (01) :88-91
[9]  
Davis S, 1996, AM J HUM GENET, V58, P867
[10]   Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers [J].
Deakin, M ;
Elder, J ;
Hendrickse, C ;
Peckham, D ;
Baldwin, D ;
Pantin, C ;
Wild, N ;
Leopard, P ;
Bell, DA ;
Jones, P ;
Duncan, H ;
Brannigan, K ;
Alldersea, J ;
Fryer, AA ;
Strange, RC .
CARCINOGENESIS, 1996, 17 (04) :881-884